Gemcitabine
2024-0279
Phase 2 small_molecule active
Quick answer
Gemcitabine for Metastatic Biliary Tract Cancer is a Phase 2 program (small_molecule) at Compass Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Compass Therapeutics
- Indication
- Metastatic Biliary Tract Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active